Reuters logo
BRIEF-Vanc Pharmaceuticals receives Health Canada class-III approval for ferrous fumarate products
September 8, 2017 / 7:12 PM / 2 months ago

BRIEF-Vanc Pharmaceuticals receives Health Canada class-III approval for ferrous fumarate products

Sept 8 (Reuters) - Vanc Pharmaceuticals Inc

* Vanc pharmaceuticals receives health canada class-iii approval for ferrous fumarate products

* Vanc pharmaceuticals inc - ‍has received health canada class-iii approval of ferrous fumarate tablets and capsules for use in iron deficiency anemia​

* Vanc pharmaceuticals inc - that it will not be proceeding with 2nd tranche closing of non-brokered private placement announced july 20, 2017​

* Vanc pharmaceuticals inc - ‍plans to secure additional financing in due course​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below